In these sessions, the epidemiology and clinical associations of important pathogens in cystic fibrosis will be presented. Speakers will present evidence on pathogen evolution over time, novel scoring systems for defining chronicity, and the impact of emerging therapies on the effectiveness of existing antimicrobials.
Describe the epidemiology, clonal spread, and resulting clinical associations of common CF pathogens.
Propose a novel scoring system for chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Discuss the impact of novel small molecule therapies on antimicrobial effectiveness for traditional cystic fibrosis pathogens.